Related Experiment Videos
Immunohistochemical studies from vitiligo--comparison between active and inactive lesions
1Department of Dermatology, Yonsei University Wonju College of Medicine, Korea.
Yonsei Medical Journal
|December 1, 1994
Summary
This study investigated vitiligo pathogenesis by examining skin lesions. Increased ICAM-1, HLA-DR, and CD4+ T-lymphocyte expression in active vitiligo suggests their role in disease progression.
Area of Science:
- Immunodermatology
- Pathogenesis of autoimmune disorders
Background:
- Vitiligo is an acquired depigmenting disorder with unknown causes.
- Understanding the molecular mechanisms of vitiligo is crucial for developing effective treatments.
Purpose of the Study:
- To elucidate the pathogenesis of vitiligo by examining immune markers in active and stable lesions.
- To investigate the expression of ICAM-1, HLA-DR, CD4, and CD8 in vitiligo skin.
Main Methods:
- Immunohistochemical analysis of active and stable vitiligo skin margins.
- Utilized monoclonal antibodies for ICAM-1, HLA-DR, CD4, and CD8.
Main Results:
- ICAM-1 and HLA-DR were significantly upregulated in the epidermis of active vitiligo lesions compared to stable ones.
- Dermal ICAM-1 and HLA-DR expression was observed in both active and stable lesions.
- CD4+ lymphocytes showed increased expression in active lesions, while CD8+ lymphocytes did not differ significantly.
Conclusions:
- ICAM-1 and HLA-DR expression, along with activated T-lymphocyte infiltration, are implicated in vitiligo disease activity.
- Cytokine involvement from keratinocytes, melanocytes, or lymphocytes may contribute to the pathogenesis.
- These findings highlight key immune players in the progression of vitiligo.